Tech Company Financing Transactions
Arda Therapeutics Funding Round
Arda Therapeutics closed a $43 million Series A funding round on 10/9/2024. Investors included Andreessen Horowitz, Alumni Ventures and Biovision Ventures.
Transaction Overview
Company Name
Announced On
10/9/2024
Transaction Type
Venture Equity
Amount
$43,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
930 Brittan Ave
San Carlos, CA 94070
USA
San Carlos, CA 94070
USA
Phone
Undisclosed
Website
Email Address
Overview
Arda is taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions. Our approach starts by using single-cell data to identify pathogenic cells to target and how to target them. We then design therapies to eliminate these - and only these - cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Adam Freund
Chief Scientific Officer
Scott Turner
Chief Technical Officer
Remi Laberge
Browse more venture capital transactions:
Prev: 10/9/2024: Logik.io venture capital transaction
Next: 10/9/2024: Q-CTRL venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs